Findings

What do systematic reviews say?

5 questions · 5 findings · 3 reviews · Eyes and Vision

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 40%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 3 · 60%High 0 · 0%

Anti‐VEGF vs laser

QoL · people with BRVO

The review found no eligible studies for this question.

1 finding from 1 review

Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Anti‐VEGF vs steroids

QoL · people with BRVO

1 finding from 1 review

Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 307 participants
Moderate

Anti‐VEGF vs sham

QoL · macular oedema secondary to branch retinal vein occlusion

1 finding from 1 review

Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 281 participants
Moderate

Radiotherapy combined with anti‐VEGF vs anti‐VEGF alone

Contrast sensitivity (log contrast threshold) Measured using a Pelli‐Robson chart. Higher scores represent better contrast sensitivity. · people with neovascular AMD

The review found no eligible studies for this question.

1 finding from 1 review

Radiotherapy for neovascular age‐related macular degeneration 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Anti‐vascular endothelial growth factor (anti‐VEGF) with or without pan‐retinal photocoagulation (PRP) vs PRP alone

Visual acuity · proliferative diabetic retinopathy

1 finding from 1 review

Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy 2023 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 1172 participants
Moderate